I'm a strong believer in the efficacy and long-term prospects of this company. Their product is a definite game-changer for the future health of many thousands of patients all over the world. Their position, product, timing and strategy is completely compelling in my view. All we need is for a few more major hospital chains to realise the financial windfall of implementing the Dyevert system into their operations and this will surely take off.
That's my genuine view as a long term holder sitting on a 50% loss (bought heavily a few years ago), but topped up even more heavily recently. I expect this stock to do very well over the next 1-3 years. All in my opinion only.
Cheers
OSP Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
